UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Optimising primary molecular profiling in non-small cell lung cancer

PloS one, 2024-07, Vol.19 (7), p.e0290939

2024

Volltextzugriff (PDF)

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial

BMC cancer, 2018-11, Vol.18 (1), p.1146-1146, Article 1146

2018

Volltextzugriff (PDF)

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

Gynecologic oncology, 2022-08, Vol.166 (2), p.284-291

2022

Volltextzugriff (PDF)

The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-11, Vol.161, p.141-151

2021

Volltextzugriff (PDF)

Incidence of lymph node metastases in clinical early‐stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2017-02, Vol.124 (3), p.486-494

2017

Volltextzugriff (PDF)

Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin

Gynecologic oncology, 2015-03, Vol.136 (3), p.562-566

2015

Volltextzugriff (PDF)

Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC

JTO clinical and research reports, 2023-04, Vol.4 (4), p.100481-100481, Article 100481

2023

Volltextzugriff (PDF)

Effects of heat and moisture exchangers on tracheal mucociliary clearance in laryngectomized patients: a multi-center case–control study

European archives of oto-rhino-laryngology, 2015-11, Vol.272 (11), p.3439-3450

2015

Volltextzugriff (PDF)

Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath

Annals of oncology, 2019-10, Vol.30 (10), p.1660-1666

2019

Volltextzugriff (PDF)

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

European journal of cancer (1990), 2022-08, Vol.171, p.114-123

2022

Volltextzugriff (PDF)

158P PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel–carboplatin–bevacizumab with or without nitroglycerin

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S126-S127

2016

Volltextzugriff (PDF)

Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma

Lung cancer (Amsterdam, Netherlands), 2024-01, Vol.187, p.107440-107440, Article 107440

2024

Volltextzugriff (PDF)

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Breast cancer research and treatment, 2022-07, Vol.194 (2), p.265-278

2022

Volltextzugriff (PDF)

Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approaches

Prostate cancer and prostatic diseases, 2024-06, Vol.27 (2), p.312-317

2024

Volltextzugriff (PDF)

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy

Clinical genitourinary cancer, 2024-04, Vol.22 (2), p.445-453.e1

2024

Volltextzugriff (PDF)

Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer

Virchows Archiv : an international journal of pathology, 2017-06, Vol.470 (6), p.655-664

2017

Volltextzugriff (PDF)

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)

Annals of oncology, 2015-11, Vol.26 (11), p.2286-2293

2015

Volltextzugriff (PDF)

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

Radiotherapy and oncology, 2020-03, Vol.144, p.65-71

2020

Volltextzugriff (PDF)

Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer

Oral oncology, 2019-08, Vol.95, p.143-149

2019

Volltextzugriff (PDF)

The effect of prophylactic cranial irradiation (PCI) for young stage III NSCLC patients: Subgroup analyses of the NVALT-11/DLCRG-02 study

Annals of oncology, 2019-04, Vol.30, p.ii33-ii34

2019

Volltextzugriff (PDF)

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

Acta oncologica, 2019-10, Vol.58 (10), p.1528-1531

2019

Volltextzugriff (PDF)

PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease

European journal of surgical oncology, 2017-04, Vol.43 (4), p.625-635

2017

Volltextzugriff (PDF)

PET/CT with 18 F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease

European journal of surgical oncology, 2017-04, Vol.43 (4), p.625-635

2017

Volltextzugriff (PDF)

St. Gallen endocrine response classes predict recurrence rates over time

Breast (Edinburgh), 2015-12, Vol.24 (6), p.705-712

2015

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(136)
Japanisch
(16)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(54)
Humans
(41)
Physical Sciences
(28)
Oncology
(24)
Chemistry
(23)
Female
(18)
Middle Aged
(17)
Aged
(16)
Male
(14)
Chemistry, Organic
(13)
Surgery
(11)
Adult
(10)
Biological And Medical Sciences
(10)
Patients
(10)
Peptides
(10)
Amino Acid Sequence
(9)
Biochemistry & Molecular Biology
(9)
Molecular Structure
(9)
Anti-Bacterial Agents - Pharmacology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

Optimising primary molecular profiling in non-small cell lung cancer

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

Incidence of lymph node metastases in clinical early‐stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study

Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin

Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC

Effects of heat and moisture exchangers on tracheal mucociliary clearance in laryngectomized patients: a multi-center case–control study

Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

158P PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel–carboplatin–bevacizumab with or without nitroglycerin

Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approaches

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy

Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer

The effect of prophylactic cranial irradiation (PCI) for young stage III NSCLC patients: Subgroup analyses of the NVALT-11/DLCRG-02 study

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease

PET/CT with 18 F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease

St. Gallen endocrine response classes predict recurrence rates over time

Suchergebnisse filtern